Related Experiment Video
Updated: Feb 6, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Hypertriglyceridemia Causing Continuous Renal Replacement Therapy Dysfunction in a Patient with End-stage Liver
D C McLaughlin1, D C Fang2, B A Nolot3
1Department of Critical Care, Mayo Clinic, Florida, USA.
Severe hypertriglyceridemia can impede continuous renal replacement therapy (CRRT) in critically ill patients. Prompt intervention, like therapeutic plasma exchange, is crucial for managing filter clotting and life-threatening complications.
Area of Science:
- Nephrology
- Critical Care Medicine
- Hepatology
Background:
- Continuous renal replacement therapy (CRRT) is vital for critically ill patients with kidney injury.
- Hypertriglyceridemia is an uncommon but serious complication that can disrupt CRRT.
- Liver transplant recipients are susceptible to metabolic derangements.
Observation:
- A critically ill liver transplant patient experienced recurrent filter clotting during CRRT.
- Elevated serum triglycerides (TGs) led to lipemic blood, rendering the dialytic circuit nonfunctional.
- This nonfunctionality posed immediate risks of hyperkalemia and metabolic acidosis.
Findings:
- Persistent hypertriglyceridemia, attributed to medication side effects and liver graft failure, caused CRRT circuit failure.
- Emergent therapeutic plasma exchange successfully lowered TG levels, enabling resumption of CRRT.
- The patient's hypertriglyceridemia and liver dysfunction resolved after a second liver transplant.
Implications:
- Highlights the critical need to monitor triglyceride levels in critically ill patients undergoing CRRT.
- Underscores the potential for severe hypertriglyceridemia to cause CRRT malfunction.
- Demonstrates the efficacy of therapeutic plasma exchange in managing this complication and the importance of addressing underlying causes like liver failure.
More Related Videos
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Gene Therapy
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

